Revolution Medicines (FRA:42Z) Current Accrued Expense : €77.72 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Revolution Medicines Current Accrued Expense?

Revolution Medicines's Current Accrued Expense for the quarter that ended in Mar. 2025 was €77.72 Mil.

Revolution Medicines's quarterly Current Accrued Expense increased from Sep. 2024 (€51.95 Mil) to Dec. 2024 (€62.32 Mil) and increased from Dec. 2024 (€62.32 Mil) to Mar. 2025 (€77.72 Mil).

Revolution Medicines's annual Current Accrued Expense increased from Dec. 2022 (€14.78 Mil) to Dec. 2023 (€43.27 Mil) and increased from Dec. 2023 (€43.27 Mil) to Dec. 2024 (€62.32 Mil).

Revolution Medicines Current Accrued Expense Historical Data

The historical data trend for Revolution Medicines's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revolution Medicines Current Accrued Expense Chart

Revolution Medicines Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Accrued Expense

Get a 7-Day Free Trial

9.00

15.54

14.78

43.27

62.32

Revolution Medicines Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Accrued Expense	Get a 7-Day Free Trial															39.23	48.58	51.95	62.32	77.72

Revolution Medicines Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Revolution Medicines Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Revolution Medicines's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Revolution Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Revolution Medicines Inc (FRA:42Z) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

RVMD:USA 42Z:Germany

Address

700 Saginaw Drive, Redwood City, CA, USA, 94063

Website

https://www.revmed.com

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Revolution Medicines Headlines

No Headlines